NYLIM
WST icon

New York Life Investment Management’s West Pharmaceutical WST Stock Holding History

New York Life Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.67M Buy
10,672
+267
+3% +$66.4K 0.02% 474
2025
Q4 		$2.86M Sell
10,405
-72
-0.7% -$19.7K 0.02% 447
2025
Q3 		$2.75M Sell
10,477
-271
-3% -$65.9K 0.02% 473
2025
Q2 		$2.35M Sell
10,748
-26
-0.2% -$5.56K 0.02% 500
2025
Q1 		$2.41M Sell
10,774
-51
-0.5% -$14.1K 0.02% 494
2024
Q4 		$3.55M Buy
10,825
+84
+0.8% +$26.4K 0.03% 412
2024
Q3 		$3.22M Sell
10,741
-375
-3% -$115K 0.03% 453
2024
Q2 		$3.66M Sell
11,116
-43
-0.4% -$15.2K 0.04% 413
2024
Q1 		$4.42M Sell
11,159
-391
-3% -$145K 0.04% 366
2023
Q4 		$4.07M Buy
11,550
+88
+0.8% +$31.1K 0.04% 367
2023
Q3 		$4.3M Sell
11,462
-114
-1% -$44.1K 0.05% 337
2023
Q2 		$4.43M Sell
11,576
-36
-0.3% -$12.9K 0.05% 343
2023
Q1 		$4.02M Sell
11,612
-7,538
-39% -$2.2M 0.04% 359
2022
Q4 		$4.51M Sell
19,150
-181
-0.9% -$42.9K 0.05% 348
2022
Q3 		$4.75M Sell
19,331
-445
-2% -$136K 0.06% 319
2022
Q2 		$5.98M Buy
+19,776
New +$6.43M 0.07% 276

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

New York Life Investment Management's WST Position: Q1 2026 in Review

New York Life Investment Management increased its West Pharmaceutical (WST) stake by 2.6% in Q1 2026, buying an estimated $66.4K and bringing the position to 10,672 shares worth $2.67M. The position accounts for 0.02% of the portfolio, ranked #474.

New York Life Investment Management first reported a position in WST in Q2 2022 and has held it in 16 quarters since. The position peaked at $5.98M in Q2 2022. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • New York Life Investment Management held 10,672 shares of West Pharmaceutical worth $2.67M as of Q1 2026.
  • New York Life Investment Management bought 267 West Pharmaceutical shares in Q1 2026, an estimated $66.4K.
  • West Pharmaceutical made up 0.02% of New York Life Investment Management's portfolio in Q1 2026, its #474 holding.
  • New York Life Investment Management first reported a position in West Pharmaceutical in Q2 2022 and has held it in 16 quarters since.
  • New York Life Investment Management's West Pharmaceutical position peaked at $5.98M in Q2 2022.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on New York Life Investment Management's 13F filing for Q1 2026, filed 7 May 2026.